Antiverse

United Kingdom
Cardiff, Wales, United Kingdom, CF24 4HQ

Company profile

Antiverse company profile

Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-04-01, Month

Headquarters

Postal code
CF24 4HQ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
9
Total equity funding
$9.9M
Last funding
Seed / $4.6M / 2024-10-15
Last equity funding
Seed / $4.6M
Investors
18
Lead investors
6
Founders
3
Articles
18

Founders and investors

Founders

Ben HollandMurat TunaboyluRowina Westermeier

Lead investors

Accelerate@Babrahami&i Biotech FundInnospark VenturesKadmos CapitalUK Innovation & Science Seed FundVentureOut

Investors

ACF InvestorsDevelopment Bank of WalesFuture Planet CapitalSyndicateRoomTensor Ventures